Who owns Mirati Therapeutics?
- CUSIP Number: 60468t105
Tip: Access positions for across all investors
Analyze quarterly positions in Mirati Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv Download as ExcelTop investors of Mirati Therapeutics stock
Who bought or sold Mirati Therapeutics this quarter?
Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
---|---|---|---|---|---|
venBio Select Advisor | 4.9M | $287M | -27% | Dec 2023 |
|
Sawtooth Asset Management | 3.1M | $184M | 100% | Dec 2023 |
|
Hsbc Holdings | 783k | $46M | 100% | Dec 2023 |
|
Alliancebernstein | 739k | $43M | 517% | Dec 2023 |
|
National Bank Of Canada /fi/ | 474k | $28M | 100% | Dec 2023 |
|
Madison Avenue Partners | 417k | $25M | 100% | Dec 2023 |
|
Healthcare Of Ontario Pension Plan Trust Fund | 381k | $22M | 100% | Dec 2023 |
|
Sand Grove Capital Management | 225k | $13M | 100% | Dec 2023 |
|
Bank of Nova Scotia | 72k | $4.2M | 100% | Dec 2023 |
|
Alberta Investment Management Corporation | 44k | $2.6M | 100% | Dec 2023 |
|
Kellner Capital | 41k | $2.4M | 100% | Dec 2023 |
|
Guggenheim Capital, LLC Managers | 34k | $2.0M | 8% | Dec 2023 |
|
Algert Coldiron Investors | 18k | $1.1M | -76% | Dec 2023 |
|
IFP Advisors | 3.7k | $216k | 0% | Dec 2023 |
|
Federated Investors | 1.4k | $85k | 100% | Dec 2023 |
|
Lazard Asset Management | 1.3k | $76k | 100% | Dec 2023 |
|
MetLife Investment Advisors | 1.1k | $63k | 18% | Dec 2023 |
|
American International | 450.00 | $26k | 17% | Dec 2023 |
|
Coppell Advisory Solutions | 429.00 | $24k | 100% | Dec 2023 |
|
Itau Unibanco Holding | 135.00 | $7.9k | -16% | Dec 2023 |
|
EverSource Wealth Advisors | 42.00 | $2.5k | 0% | Mar 2024 |
|
Sachetta | 24.00 | $1.4k | 0% | Mar 2024 |
|